Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Renal Cell Carcinoma
Related studies linked through entity extraction aliases.
A Study to Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.
- Status
- TERMINATED
- Phase
- PHASE1
Planning Operative Strategy Using a Digital Renal Artery Clamping Tool
- Status
- RECRUITING
- Phase
- NA
Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Study of AK112 Monotherapy in Advanced/Metastatic Renal Cell Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Evaluation of a Simple-Prep Controlled Embolic
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of VET3-TGI in Patients With Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.
- Status
- RECRUITING
- Phase
- NA
Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study of Anti-CD70 UCAR-T in Relapsed or Refractory Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
- Status
- RECRUITING
- Phase
- N/A
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy
- Status
- RECRUITING
- Phase
- N/A
European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)
- Status
- RECRUITING
- Phase
- N/A
Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Evaluation of the Safety of Reoperation for Ipsilateral Recurrent Tumors After Nephron-sparing Partial Nephrectomy
- Status
- COMPLETED
- Phase
- N/A
A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1